ESG Issues and Disclosures for Biotechnology & Pharmaceuticals Companies – Bloomberg Law

The Sustainability Accounting Standards Board (SASB) has developed a sustainability accounting standard for the biotechnology and pharmaceuticals industries (the Standard), which consists of disclosure topics, accounting metrics and activity metrics. Fenwick corporate partners Amanda Rose and counsel Ron Llewellyn recently published several materials in Bloomberg Law’s ESG Health Toolkit for biotechnology & pharmaceutical companies, including an overview summarizing the issues in the industry and a checklist for companies to follow the SASB standards.

Read the Overview: ESG Issues for Biotechnology & Pharmaceuticals Companies 

Read the Checklist: ESG Disclosures for Biotechnology & Pharmaceuticals Companies (Annotated) 


Don’t have an account yet?